Skip to main content

August 2016

 

 

academics

 

Clinical research courses

PharmaTutor Magazine - September 2016 is released | Subscribe today

Mylan N.V. announced that its U.S. subsidiary will launch the first generic to EpiPen® Auto-Injector (epinephrine injection, USP) at a list price of $300 per generic EpiPen® two-pack carton, which represents a discount of more than 50% to the Mylan list price, or wholesale acquisition cost ("WAC"), of the branded medicine. The authorized generic will be identical to the branded product, including device functionality and drug formulation. Mylan expects to launch the product in several weeks, pending completion of labeling revisions. Upon launch, the product will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths. Mylan also intends to continue to market and distribute branded EpiPen®.

Tonix Pharmaceuticals  Holding Co. which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced that it has received the final meeting minutes from the U.S. Food and Drug Administration (FDA) from an  End-of-Phase 2/Pre-Phase 3 meeting. These minutes confirmed the FDA’s acceptance of Tonix’s proposed Phase 3 studies and the planned New Drug Application (NDA) data package to support the registration of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of PTSD.

Information About GPAT and Other enterances
Work as Technical Documentation Executive in Caliber Technologies - 05 Posts | B.Pharma/ M.Pharma/ B.Sc

Caliber Technologies Pvt. Ltd. is a company formed in Aug 2001 with a focus on solutions for Pharma and biotech industries. Caliber's core competency lies in building solutions for Pharma and laboratory activities and solutions for international quality standards and regulatory norms like GLP, FDA, and GAMP. We have developed a portfolio of competencies out of this core competency.
The company's flagship product CaliberLIMS® is designed using cutting edge technologies to help the Pharma/ biotech companies to comply to the stringent international regulatory norms like Electronic Signatures and Electronic Records (21CFR PART 11), GAMP etc. Implementation of CaliberLIMS® would reduce the risk of regulatory non-conformance. It is thus an Enterprise Quality Management tool for the regulated industry. Apart from its flagship product CaliberLIMS®, Caliber offers other software solutions for the regulated industries with a suite of products such as Caliber Stability, Caliber TRIMS, Caliber EM and Caliber CLAPS. It also has other products in the pipeline like Caliber CLINSTAR (Clinical Trials LIMS), Caliber eDox (Document Management System) and Caliber CAPA. The Company's products are innovative, highly configurable, integrate well with SAP etc., and are user friendly.

Drug Inspector Question Paper 2009 -TNPSC

1. Which of the following trademarked sustained release systems are based on encapsulated drug particles that will dissolve at various rates ?  
I.   Sequels
II.   Spansules
III.  Extentabs.
Of these
A)  I only
B)  III Only
C) I and II
D) I, II, and III

Career as Chief Manager under the Department of Health and Family Welfare at DHCL | Remuneration Rs.1,50,000/-

Delhi government has established Delhi Healthcare Corporation Limited (DHCL), a public limited company, under the Department of Health and Family Welfare of Government of National Capital Territory of Delhi (GNCTD). DHCL is mandated to provide administrative support services to health facilities of Delhi Govt. including procurement and ensuring availability of drugs, consumables, equipment, setting up and running of laboratory services, management of outsourced hospital services, smooth running of Aam Aadmi Mohalla clinics, technology services etc. ). DHCL will provide these services by setting up four Strategic Business Units (SBU) Procurement & Supply Chain Management Services, Hospital Management Services, Aam Aadmi Mohalla Clinic (AAMC) Management Services and Information Technology Services. To carry out the functions and tasks effectively, the Delhi Healthcare Corporation invites applications for following below mentioned posts in the prescribed format from suitable candidates on a contractual / deputation basis.

Post : Chief Manager – Procurement of Drugs & Consumables